Contract manufacturer Biodeal Pharma raises Rs.110-Cr from Piramal Alternatives

Piramal Alternatives is investing INR 110 crore in Noida-headquartered Biodeal Pharmaceuticals Ltd , a contract development and manufacturing company. The funds would be used to improve infrastructure and capacities, upgrade technology, and set up a dedicated nutraceuticals manufacturing facility.Biodeal’s product basket includes dosage formats, including dry powder inhalation capsules, capsules, tablets, ointments, lotions, and dusting powder.